Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: South Korea Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20062
20075
20083
20093
20102
20111
20125
20134
20141
20153
20162
20172
20185
20193
20208
202110
20226
20232
20249
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting20
Unknown status16
Active, not recruiting9
Terminated7
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center11
Seoul National University Hospital7
Korea Cancer Center Hospital5
Merck Sharp & Dohme LLC5
Samsung Medical Center4
Seagen, a wholly owned subsidiary of Pfizer3
AstraZeneca2
Eli Lilly and Company2
GOG Foundation2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms87
Ovarian Neoplasms20
Endometrial Neoplasms19
Carcinoma, Non-Small-Cell Lung12
Squamous Cell Carcinoma of Head and Neck12
Breast Neoplasms10
Colorectal Neoplasms10
Stomach Neoplasms10
Esophageal Neoplasms9
Pancreatic Neoplasms8

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.